This is the second of a series of articles to tackle some of the misconceptions around the Lateral Flow Device (LFD) service. The articles will cover a variety of aspects of the LFD service and aims to myth bust, to increase understanding of the service. All patients who are eligible for a COVID-19 vaccination are [...]
The post LFD service myth busting series (#2) appeared first on Community Pharmacy England.
This Medicines Supply Notification supersedes the National Patient Safety Alert issued on 29 July 2025 Department of Health and Social Care (DHSC) has issued a medicine supply notification for Antimicrobial Agents Used in Tuberculosis (TB) Treatment MSN/2025/058 Tier 3 – high impact Date of issue: 23rd October 2025 Following the National Patient Safety Alert issued [...]
The post Medicine Supply Notification: Antimicrobial Agents Used in Tuberculosis (TB) Treatment appeared first on Community Pharmacy England.
Pharmacist flexibilities “should be the norm”, Community Pharmacy England has said in a draft response to Government proposals. A Department of Health and Social Care’s (DHSC’s) consultation is proposing enabling community pharmacists to supply a different strength or formulation (which may mean a different quantity) of the same medicine originally prescribed where the prescribed medicine [...]
The post Community Pharmacy England publishes draft response to pharmacist flexibilities consultation appeared first on Community Pharmacy England.
The Department of Health and Social Care (DHSC) has today (23/10/2025) confirmed the following list of price concessions for October 2025: Drug Pack size Price concession Alfuzosin 2.5mg tablets 60 £6.85 Bumetanide 1mg tablets 28 £2.95 Buprenorphine 8mg sublingual tablets sugar free 7 £3.85 Clarithromycin 125mg/5ml oral suspension 70 £10.88 Clarithromycin 250mg/5ml oral suspension 70 £19.67 Duloxetine [...]
The post October 2025 Price Concessions 2nd Update appeared first on Community Pharmacy England.
MHRA Class 3 Medicines Recall: Ipratropium Bromide 500 microgram / 2ml Nebuliser Solution (Accord Healthcare Ltd) Drug Alert Number: EL(25)A/45 Date issued: 23 October 2025 Accord Healthcare Ltd is recalling a batch of Ipratropium Bromide 500 microgram/2ml Nebuliser Solution after a foil pouch was found to contain ampoules with incorrect labels intended for the Korean market. [...]
The post MHRA Class 3 Medicines Recall: Ipratropium Bromide 500 microgram / 2ml Nebuliser Solution (Accord Healthcare Ltd) appeared first on Community Pharmacy England.
Recent Comments